Skip to content
Menu

BioNexus Gene Lab Corp. BGLC

Full chart Compare
Set alert

Price alert · BGLC

All alert types
0.68 USD -0.05 (-7.29%)

Regular-session close

0.68 0.00 0.00%

After hours · Nov 19, 4:00 PM ET

0.6586 Day range 0.753
0.6586 52-week range 4.97
YTD
-82.78%
1 year
-85.80%

Revenue & Expenses

Revenue Profit Costs
Other Income$173.84KGross Profit$1.09MNet Loss$2.98MCost of Revenue$6.34MExpenses$4.24MSelling, General & Admin$4.07MResearch & Development$50.67KOther Operating Expenses$126.44KRevenue$7.42M

Latest period ending Dec 31, 2025 · select a line to chart its full history

BGLC annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
7.42M9.51M9.77M10.93M13.36M
1.09M1.29M1.33M1.26M2.27M
-3.40M-3.65M-3.08M-470.46K989.34K
-2.98M-1.60M-2.63M-355.97K751.57K
-1.61-0.897-1.66-0.460.48
BGLC annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
2.38M1.58M2.62M611.85K578.51K
9.25M10.43M11.40M8.74M9.57M
637.86K2.11M1.74M2.08M2.39M
225.53K227.73K146.59K56.77K76.95K
8.61M8.32M9.66M6.67M7.18M
BGLC annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-1.84M-2.09M-1.82M551.82K9.16K
944.75K418.20K-1.79M-450.50K-490.57K
298.84K3.98K6.27M108.17K-28.22K
-36.97K-226.99K-149.40K-54.17K-3.16K
-400.58K-1.63M2.40M-5.05K-663.77K